Table 1

The optimal PRSs associated with risks of stroke and its subtypes in the training sets

OutcomesMethodPRS source*No of variantsORSD (95% CI)P valueNote
Any stroke (N=7412 pairs)
Previous studyPGS0022594481.13 (1.09 to 1.16)1.44×10–11
C+TGCST005838 (p=1×10-6, r2=0)381.11 (1.07 to 1.14)1.90×10–9
LDpredGCST005838 (ρ=0.01, Ref=1KGP-EAS)1 017 5311.14 (1.10 to 1.18)3.38×10–14 Optimal
Ischaemic stroke (N=3844 pairs)
Previous studyPGS0000391 563 5691.07 (1.01 to 1.12)0.012
C+TGCST90018864 (p=0.02, r2=0.8)32 1581.18 (1.13 to 1.24)3.55×10–11 Optimal
LDpredGCST90018864 (ρ=0.01, Ref=1KGP-EUR)1 017 6721.17 (1.11 to 1.23)1.46×10–9
Intracerebral haemorrhage (N=4296 pairs)
C+TGCST90018870 (p=0.001, r2=0.2)13261.09 (1.04 to 1.14)1.37×10–4
LDpredGCST90018870 (ρ=0.1, Ref=1KGP-EUR)1 017 6641.10 (1.05 to 1.15)3.09×10–5 Optimal
Subarachnoid haemorrhage (N=359 pairs)
C+TGCST90018703 (p=0.4, r2=0)78991.25 (1.06 to 1.47)9.21×10–3 Optimal
LDpredGCST90018923 (ρ=0.01, Ref=1KGP-EUR)1 017 6651.15 (0.98 to 1.35)0.096
  • The current table only displays the optimal PRS obtained from different strategies (previous study, C+T and LDpred) for each disease outcome. The detailed results of all PRSs can be found in online supplemental table 7.

  • *'PGS’ indicates the index in the PGS Catalogue. ‘GCST’ indicates the index in the GWAS Catalogue. The information in brackets is the parameter used for developing the PRS.

  • C+T, clumping and thresholding; EAS, East Asian; EUR, European; 1KGP, 1000 Genomes Project (Phase 3); PRS, polygenic risk score; Ref, reference population.